PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma

Clinical trial NCT02615730 · COMPLETED

Trial details

NCT number: NCT02615730
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Adenocarcinoma

Start date: 2016-02-01
Primary completion: 2021-03-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.